The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Genetic alterations in HRAS gene in relation to outcome and response to cetuximab in head and neck squamous cell carcinoma.
Theodoros Rampias
No relevant relationships to disclose
Athina Giagini
No relevant relationships to disclose
Hiroumi Matsuzaki
No relevant relationships to disclose
Valentina Bartzi
No relevant relationships to disclose
Spyros Siolos
No relevant relationships to disclose
Elena Vaja
No relevant relationships to disclose
Nick Haralambakis
No relevant relationships to disclose
Panagiotis Katsaounis
No relevant relationships to disclose
Andreas Scorilas
No relevant relationships to disclose
Amanda Psyrri
No relevant relationships to disclose